TCL Archive Five-Year Course of Tamoxifen Remains Standard Treatment In HR+ Breast Cancer July 26, 2002
TCL Archive National Cancer Survey Data Available Soon: NCI Will Invite Investigators to Prepare Analysis August 23, 1974
TCL Archive Seattle Panel Meeting Generate More Support For Increased Outreach Funding, Consortium Approached November 2, 1984